A smartphone add-on, devised by an emergency medicine physician now at Stanford, detected a drunken stagger, through side-to-side sway, with 90% accuracy.
Researchers have developed a sensor system on a smartwatch that uses sweat to determine the level of acetaminophen in the body.
Stanford Medicine educators found creative ways to teach summer courses to high school and undergraduate students during the pandemic.
For a Stanford digital health biodesign course, two undergraduates developed a program to increase patients' physical therapy engagement at home.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
Stanford researchers have shown how to create wireless brain-computer interfaces that could enable amputees to operate thought-controlled prostheses.
Friends and colleagues, Stanford nephrology fellows Daniel Watford and Dimitri Augustin trained alongside each other in Florida and then both moved west.
After treating a patient with an unusual ammonia metabolism problem, a Stanford researcher assembled a team to reimagine ammonia blood testing.
Through a survey, an initiative and a speed-mentoring event, the Stanford Byers Center for Biodesign is taking on gender inequalities in health tech.
Scientists created an algorithm that analyzes a cancer biopsy and pairs spatial information with gene expression to better understand the disease.
Stanford University bioengineers are developing a faster-acting formulation of insulin that can help diabetes patients better regulate their blood sugar levels.
Tracking brainwave patterns and symptoms in patients with depression, researchers used artificial intelligence to predict best treatment options.
Technology has made it possible for Stanford Medicine residents to continue learning and caring for patients safely during the COVID-19 era.
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
A Stanford team is developing a bioscaffold that helps insulin-producing cells get enough oxygen when transplanted for diabetes treatment.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
